Lowest Price Guaranteed
Pages
245
Last Updated
June 2025
View Count
13802
The needles market is estimated to grow from USD 7.7 billion in 2024 to USD 8.1 billion in 2025 and USD 14.7 billion by 2035, representing a CAGR of 6.1% during the forecast period.
 |
To learn more about this report, request a free sample copy
Over the years, the incidence of chronic conditions, such as diabetes, autoimmune diseases, heart diseases, and cancer has risen significantly. Their management requires daily administration of drugs by patients, mostly in home settings. Medical needles have been an indispensable tool in healthcare, employed for a variety of medical procedures, including drug delivery, dental and surgical procedures, administration of vaccines and blood / specimen collection. As such, the demand for needles has significantly increased, playing a critical role in managing the growing burden of chronic diseases.
 |
 |
 |
Research and development in this domain has led to several advancements such as miniaturization of needles and use of improved materials such as reinforced steel. Additionally, development of ultra-thin pen needles that are designed to allow less painful insulin delivery, has also been game changing. Further, the recent advent of needles with a wider range of gauge sizes has helped in addressing some of the major challenges, including the need for injecting higher viscosity drugs in larger volumes, contributing to their increased adoption.
 |
 |
 |
Key needle manufacturers engaged in this market include Becton Dickinson (US) and B. Braun (Germany). Asia Pacific, specifically Japan, is also home to Terumo Corporation and Nipro Corporation, which are amongst the largest needle and syringe manufacturers.
The key opportunities for needles manufacturers is likely to be the demand for insulin pen needles, driven by the increased demand for GLP-1. Since the major manufacturers also have pharma primary packaging business, they are also targeting the value-added products such as ready to use syringes with needles.
 |
 |
 |
Shreeya Agrawal, Senior Manager, Roots Analysis states “driven by the rising need for innovative solutions and continuous improvements in material science, design and manufacturing techniques in this domain, the needles market is anticipated to experience significant growth during the forecast period.”
| Key Report Attributes | Details | |
| Historical Trend | Since 2019 | |
| Forecast Period | Till 2035 | |
| Market Size 2025 | $8.1 Billion | |
| Market Size 2035 | $14.7 Billion | |
| CAGR (Till 2035) | 6.1% | |
The needles market analysis also features the likely distribution of the current and forecasted opportunity across various segments, such as type of needle based on design, type of needle based on purpose, mode of delivery, type of material, end users and geographical regions.
We have created three market forecast scenarios, conservative, base and optimistic, to account for future uncertainties in key parameters and enhance the robustness of our model. These scenarios represent different tracks of the industry's evolution.
Innovations in needle technology, such as the development of microneedles and painless injection systems, are more patient-centric and have the potential to revolutionize an individual’s experience by reducing discomfort during a medical procedure.
Several recent developments have taken place in the field of medical needles, and we have outlined some of these below. These developments, even if they arose after our market report’s release, support the overall needles market trends detailed in our analysis.
The market research report presents an in-depth analysis of the various companies providing needles across different segments, as defined in the table below:
| Market Segmentations | Details | |
| Type of Needle based on Design |
|
|
| Type of Needle based on Purpose |
|
|
| Type of Material |
|
|
| Mode of Delivery |
|
|
| End User |
|
|
| Geographical Regions |
|
|
Owing to the increasing technological innovations, rising focus on user’s safety and the development of advanced needles, we believe that the global needles industry is likely to grow at a steady rate during the forecast period.
| Report Deliverables | Details | |
| Excel Data Packs (Complimentary) |
|
|
| Key Companies Profiled |
|
|
| PowerPoint Presentation (Complimentary) |
Available | |
| Customization Scope | 15% Free Customization | |
The “Needles Market: Industry Trends and Global Forecasts, till 2035” market report features an extensive study of the current competitive landscape, company competitiveness analysis, partnership and collaborations, patent analysis, market impact analysis and market size and future opportunities within the industry, during the forecast period.
The current market landscape features the presence of 475+ very large, large, mid-sized, small and very small needle providers. It is worth mentioning that majority (50%) of the needle providers are headquartered in Asia-Pacific. The rising prevalence of chronic diseases is leading to the establishment of numerous companies in this region. Notable examples of key players based in Asia-Pacific include (established pre-1920, in alphabetical order) Terumo Corporation, Nipro Corporation, Greiner Bio-One International, Kawamoto, PENTAX Medical and Shimadzu.
The global market for needles is likely to be worth USD 8.1 billion in the 2025; growth in this market is because of the increasing vaccination initiatives. In this context, countries are expanding their vaccination programs to cover a wider range of diseases, such as polio, diphtheria and Hepatitis B. For instance, India’s Universal Immunization Program (UIP) provides free vaccines against various preventable diseases.
As a result of these vaccination efforts, the global demand for needles is rising, and the market is likely to grow at a CAGR of 6.1% during the forecast period.
Asia-Pacific accounts for the largest share (~40%) of the global market. This can be attributed to the presence of several well-established needle providers in the region, developing innovative needles for various medical procedures including sample collection, drug delivery and wound closure.
Additionally, the advanced healthcare infrastructure and research centers in Asia-Pacific enable these needle providers to conduct the necessary research activities required to bring technological advancements to market, thereby contributing to the overall growth of the market.
Surge in chronic disease management is a primary driver of market growth, which is fueling the demand for medical and surgical devices, particularly hypodermic needles and blood collection devices. In fact, a recent report from the Center for Managing Chronic Disease at the University of Michigan reported that over 50% of the US population is affected by some form of chronic disease. In 2023, the Indian Journal of Public Health reported that approximately 8.5 million deaths occur annually in the Asia-Pacific due to chronic diseases. This alarming statistic underscores the urgent need for effective medical interventions, particularly the use of needles for drug delivery and diagnostic purposes.
According to the World Health Organization (WHO), more than 16 billion injections are administered annually, while more than 7.5 billion needles are used each year in home care settings by patients with chronic diseases such as rheumatoid arthritis, diabetes, multiple sclerosis and others
Moreover, the rise in incidence and prevalence of lifestyle disorders like diabetes, where patients require multiple injections daily, are significant contributors to the market growth. To enhance patient convenience, several companies are improving the features of insulin syringes. For instance, in November 2023, Terumo India launched an insulin syringe in the Indian market, which has a 3-bevel sharp needle with high-grade silicone surface, that causes less pain to the patients while insertion. Furthermore, in order to support the patients, meet the growing cost of diabetes management, Owen Mumford launched low-cost pen needles, UnifineOTC, in April 2025.
Additionally, expansion of vaccination programs and technological advancements, such as integration of retractable needles and shielding mechanisms, are opening new revenue opportunities for players in needles industry, globally.
Despite their benefits, the use of medical needles presents several challenges. One of the most significant issues is the improper disposal of needles. Improper medical waste management leads to environmental hazards and accidental injuries. It is worth highlighting that as per the Occupational Safety and Health Administration (OSHA), around 35% of sharps-related injuries in 2024 occurred during needle disposal. Additionally, many patients experience discomfort, pain, or anxiety related to needles, which can deter them from receiving necessary medical treatments.
Stakeholders in this domain enter into numerous partnerships and collaborations, allowing them to expand their respective product portfolios and enhance their capabilities and visibility. Notably, acquisitions are the most prominent partnership model adopted by companies in this domain. For instance, in August 2024, Italy based Medical Technology and Devices (MTD) acquired the pen needles and blood glucose monitoring devices business of Ypsomed. This acquisition helped MTD to raise its pen needles production capacity to more than 2.5 billion.
Further, a significant number of commercialization agreements and distribution agreements are also signed in the needles industry.
In the past few years, nearly 765 patents are granted / filed, demonstrating substantial efforts of researchers in this domain. Notably, the majority of the patents in this domain include limited patents (52%), followed by patent applications (37%). Interestingly, most of the patents (68%) are filed by industry players in this field.
Safety syringe and safety needles with built-in safety features, like retractable tips or protective caps, have been developed to prevent accidental needlestick injuries. Given these advancements, the growing need for effective disease management, vaccination programs and routine diagnostics, can be efficiently addressed in the future.
The market report presents an in-depth analysis, highlighting the capabilities of various stakeholders in the needles industry, across different geographies. Amongst other elements, the market report includes:
Needles are an indispensable tool used in healthcare for centuries, playing a crucial role in various medical procedures, such as administering medication, extracting fluid samples and in wound closure procedures. Over the years, extensive research and development in this domain has led to the development and commercialization of several advanced needles such as pen needles that are finer and less painful. These innovations enhance the use of needles across hospitals, diagnostic centers and homecare settings, making them vital for a wide range of therapeutic deliveries. With these advancements, the needle industry is likely to grow at a substantial rate in the near future.
Lead Author: Tanvi Chadha & Shreeya Agrawal
Lead Reviewer: Parneet Kaur
Chief Editor: Prachi Bhalla